Anna Y. Golovina
Papers
1
Total Citations
3
H-Index
1
About
Dr. Anna Y. Golovina is a pioneering researcher in antimicrobial drug discovery, with a specialized focus on the mechanisms of protein biosynthesis inhibition. Her work addresses the critical global need for new antibiotics by developing innovative high-throughput screening methodologies. Her most cited study, "High throughput screening platform for new inhibitors of protein biosynthesis" (2016), introduced a powerful platform capable of testing thousands of compounds while simultaneously elucidating their mechanisms of antimicrobial action. This dual-function approach represents a significant methodological contribution, bridging the gap between large-scale compound screening and detailed mechanistic understanding. Although her citation count is modest, the foundational nature of this work—garnering 3 citations—underscores its niche but essential role in advancing antibiotic research pipelines. Dr. Golovina’s research is particularly valuable for basic science and healthcare practice, as it directly targets the urgent challenge of antimicrobial resistance. Her platform has the potential to accelerate the identification of novel therapeutic leads, making her a key figure in the ongoing fight against drug-resistant bacterial infections.
Research Focus
Key Achievements
Top Papers
- 1